Fundamentals of health economics: A user guide to the world map

Presentation

Fundamentals of health economics: A user guide to the world map

1 / 8
Fundamentals of health economics: A user guide to the world map
1 / 8
Table of Contents
1 / 8
Why is health economics relevant to healthcare professionals?
References

1. Beecroft. BMJ Opinion 2016, blogs.bmj.com/bmj/2016/02/29/claire-beecroft-why-all-medical-students-need-an-education-in-health-economics/;
2. Kernick. Postgrad Med J 2003;79(929):147–150; 3. Jain. Perspect Med Ed 2016;5:45–7

1 / 8
Introduction to health economics
1 / 8
The economics of healthcare
References
  1. Kernick. Postgrad Med J 2003;79(929):147–150; 
  2. Phillips. Health Economics: An Introduction for Health Professionals. Blackwell, 2005;
  3. Drummond. An Introduction to Health Economics. BrookwoodMedical Publications, 1995
1 / 8
The costs of healthcare
References

1. Phillips. Health Economics: An Introduction for Health Professionals. Blackwell, 2005;
2. Drummond. An Introduction to Health Economics. BrookwoodMedical Publications, 1995

1 / 8
Weighing up costs and benefits of treatments
References

1. Kernick. Postgrad Med J 2003;79(929):147–150; 
2. Phillips. Health Economics: An Introduction for Health Professionals. Blackwell, 2005

1 / 8
Cost–effectiveness comparisons
References

1. Phillips. Health Economics: An Introduction for Health Professionals. Blackwell, 2005; 
2. Kernick. Postgrad Med J 2003;79(929):147–150

1 / 8
Types of health economic evaluations
Slide information
References

DALY=disability-adjusted life year
QALY=quality-adjusted life year

1. Aredaet al. Br J PharmaceutSci 2011;47(2):231–240; 
2. Drummond. An Introduction to Health Economics. BrookwoodMedical Publications, 1995;
3. York Health Economics Consortium website. yhec.co.uk/glossary/budget-impact-analysis

1 / 8
Types of budget-impact models
Slide information

Adapted from
York Health Economics Consortium website. yhec.co.uk/glossary/budget-impact-analysis;

Lundbeck Institute Campus website. World map, draft; Mtechwebsite. mtechaccess.co.uk/all-services/budget-impact-modelling/;

Silva et al. Epidemiol ServSaude2017;26(2):421–424

1 / 8
User guide for the world map
1 / 8
Incidence and prevalence
References

1. Oxford. Concise Colour Medical Dictionary. 4thedition, 2007

1 / 8
Health utility scores
Slide information
References

aDisability weights are presented for untreated condition;

MDD=major depressive disorder

  1. Phillips. Health Economics: An Introduction for Health Professionals. Blackwell, 2005;
  2. Prüss-Üstünet al. Introduction and methods. Assessing the environmental burden of disease at national and local levels. WHO, 2003;
  3. WHO. Global Burden of Disease 2004 Update. WHO, 2008
1 / 8
QALYs and DALYs (I)
Slide information
References

DALY=disability-adjusted life year
HRQoL=health-related quality of life
QALY=quality-adjusted life year
YLD=years lived with disability
YLL=years of life lost

  1. Sassi. Health Policy Plan 2006;21(5):402–408; 2. Gold et al. Ann Rev Public Health 2002;23:115–134;
  2. Phillips. Health Economics: An Introduction for Health Professionals. Blackwell, 2005; 
  3. Prüss-Üstünet al. Introduction and methods. Assessing the environmental burden of disease at national and local levels. WHO, 2003; 
  4. Murray & Lopez. The Global Burden of Disease. WHO, 1996
1 / 8
QALYs and DALYs (II)
Slide information

Adapted from
Gold et al. Ann Rev Public Health 2002;23:115–134

1 / 8
How DALYs work in practice for an individual
Slide information
References

a80 years was the life expectancy of a Japanese male, which is used as the male benchmark for DALYs2

AD=Alzheimer’s disease
DALY=disability-adjusted life year
WHO=World Health Organization
YLD=years lived with disability
YLL=years of life lost

  1. Prüss-Üstünet al. Introduction and methods. Assessing the environmental burden of disease at national and local levels. WHO, 2003
  2. Murray & Lopez. The Global Burden of Disease. WHO, 1996
1 / 8
Cost per patient
Slide information

aSometimes considered within indirect costs

Adapted from
ADI World Alzheimer Report 2015; 

Bovolentaet al. Clin IntervAging 2017;12:2095–2108;

Greenberg et al. J Clin Psychiatry 2003;64(12):1465–1475; 

Gustavssonet al. Eur Neuropsychopharmacol2011;21:718–779;

Jin & Mosweu. Pharmacoeconomics 2017;35(1):25–42;

Kowal et al. Mov Disord2013;28(3):311–318; Mudiyanselageet al. ParkinsonsDis 2017;2017:5932675;

Okumura & Higuchi. Prim Care Companion CNS Disord2011;13(3):PCC.10m01082; 

Teoh et al. NeuropsychiatrDis Treat 2017;13:1979–1987;

Wu et al. J Clin Psychiatry 2005;66(9):1122–1129;

Yang & Chen. ParkinsonsDis 2017;2017:8762939; 

Zhaiet al. Int J MentHealth Syst2013;7(1):26;

Zhang et al. NeuropsychiatrDis Treat 2016;12:941–949;

Zhao et al. Eur J Neurol2011;18(3):519–526

1 / 8
Budget impact
1 / 8
Disease investment
1 / 8
Summary
Slide information
References

DALY-disability-adjusted life year
QALY=quality-adjusted life year

  1. Kernick. Postgrad Med J 2003;79(929):147–150;
  2. Gold et al. Ann Rev Public Health 2002;23:115–134; 
  3. Lundbeck Institute Campus website. World map, draft
Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country